The use of CTCs and their potential to analyse PD‐L1 expression has already been reported in patients with NSCLC [51, 57, 58, 59, 60, 61, 62, 63], including the study by Janning, but their significance is not yet clear [64]. Here, CD274 is linked to non-small cell lung carcinoma.